Enclosed: Invitation to Access Our Latest Research Project
Here is the latest financial fact sheet of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE quarterly results and STRIDES PHARMA SCIENCE share price and chart. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.2 |
No. of shares | m | 89.80 |
1 Week | % | -0.6 |
1 Month | % | 0.6 |
1 Year | % | -49.4 |
52 week H/L | Rs | 700.0/263.5 |
No. of Mths Year Ending |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
5-Yr Chart Click to enlarge
|
---|
STRIDES PHARMA SCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,259 | 1,148 | 720 | 547 | 1,000 | |
Low | Rs | 918 | 641 | 334 | 271 | 304 | |
Sales per share (Unadj.) | Rs | 427.9 | 373.7 | 347.0 | 332.8 | 369.7 | |
Earnings per share (Unadj.) | Rs | 49.8 | 78.3 | 41.9 | 15.4 | 39.6 | |
Diluted earnings per share | Rs | 49.6 | 78.1 | 41.8 | 15.3 | 39.6 | |
Cash flow per share (Unadj.) | Rs | 72.1 | 100.0 | 61.1 | 36.4 | 62.6 | |
Dividends per share (Unadj.) | Rs | 4.50 | 2.00 | 3.00 | 14.00 | 2.50 | |
Adj. dividends per share | Rs | 4.48 | 1.99 | 2.99 | 13.96 | 2.50 | |
Avg Dividend yield | % | 0.4 | 0.2 | 0.6 | 3.4 | 0.4 | |
Book value per share (Unadj.) | Rs | 306.4 | 274.3 | 294.9 | 281.5 | 309.1 | |
Adj. book value per share | Rs | 305.1 | 273.3 | 294.1 | 280.8 | 308.7 | |
Shares outstanding (eoy) | m | 89.42 | 89.50 | 89.57 | 89.57 | 89.68 | |
Price / Sales ratio | x | 2.5 | 2.4 | 1.5 | 1.2 | 1.8 | |
Avg P/E ratio | x | 21.8 | 11.4 | 12.6 | 26.6 | 16.4 | |
P/CF ratio (eoy) | x | 15.1 | 8.9 | 8.6 | 11.3 | 10.4 | |
Price / Book Value ratio | x | 3.6 | 3.3 | 1.8 | 1.5 | 2.1 | |
Dividend payout | % | 9.0 | 2.6 | 7.2 | 91.0 | 6.3 | |
Avg Mkt Cap | Rs m | 97,337 | 80,035 | 47,194 | 36,648 | 58,465 | |
Total wages/salary | Rs m | 4,192 | 4,341 | 3,294 | 4,426 | 5,501 |
STRIDES PHARMA SCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 38,262 | 33,444 | 31,083 | 29,811 | 33,159 | |
Other income | Rs m | 3,981 | 9,206 | 3,229 | 667 | 734 | |
Total revenues | Rs m | 42,243 | 42,650 | 34,312 | 30,478 | 33,893 | |
Gross profit | Rs m | 4,805 | 1,921 | 3,183 | 4,325 | 6,702 | |
Depreciation | Rs m | 1,987 | 1,939 | 1,718 | 1,878 | 2,063 | |
Interest | Rs m | 1,831 | 1,962 | 793 | 1,557 | 1,501 | |
Profit before tax | Rs m | 4,968 | 7,226 | 3,901 | 1,557 | 3,872 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 512 | 214 | 145 | 179 | 317 | |
Profit after tax | Rs m | 4,456 | 7,012 | 3,756 | 1,378 | 3,555 | |
Gross profit margin | % | 12.6 | 5.7 | 10.2 | 14.5 | 20.2 | |
Effective tax rate | % | 10.3 | 3.0 | 3.7 | 11.5 | 8.2 | |
Net profit margin | % | 11.6 | 21.0 | 12.1 | 4.6 | 10.7 |
STRIDES PHARMA SCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 37,918 | 24,836 | 30,487 | 23,721 | 28,172 | |
Current liabilities | Rs m | 31,039 | 18,993 | 26,622 | 25,449 | 27,383 | |
Net working cap to sales | % | 18.0 | 17.5 | 12.4 | -5.8 | 2.4 | |
Current ratio | x | 1.2 | 1.3 | 1.1 | 0.9 | 1.0 | |
Inventory Days | Days | 175 | 97 | 120 | 154 | 165 | |
Debtors Days | Days | 95 | 96 | 116 | 114 | 122 | |
Net fixed assets | Rs m | 42,430 | 41,013 | 47,581 | 35,810 | 39,996 | |
Share capital | Rs m | 894 | 895 | 895 | 896 | 897 | |
"Free" reserves | Rs m | 26,505 | 23,651 | 25,516 | 24,321 | 26,823 | |
Net worth | Rs m | 27,400 | 24,546 | 26,411 | 25,217 | 27,719 | |
Long term debt | Rs m | 16,377 | 15,513 | 18,065 | 6,039 | 8,826 | |
Total assets | Rs m | 80,349 | 65,849 | 78,068 | 59,532 | 68,168 | |
Interest coverage | x | 3.7 | 4.7 | 5.9 | 2.0 | 3.6 | |
Debt to equity ratio | x | 0.6 | 0.6 | 0.7 | 0.2 | 0.3 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | |
Return on assets | % | 7.8 | 13.6 | 5.8 | 4.9 | 7.4 | |
Return on equity | % | 16.3 | 28.6 | 14.2 | 5.5 | 12.8 | |
Return on capital | % | 15.5 | 22.9 | 10.6 | 10.0 | 14.7 | |
Exports to sales | % | 39.4 | 39.0 | 40.9 | 49.3 | 51.1 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 15,067 | 13,027 | 12,708 | 14,694 | 16,941 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 16,684 | 15,697 | 14,630 | 16,351 | 35,084 | |
Fx outflow | Rs m | 659 | 735 | 427 | 352 | 392 | |
Net fx | Rs m | 16,025 | 14,962 | 14,203 | 15,999 | 34,692 |
STRIDES PHARMA SCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,881 | 1,871 | 601 | 2,048 | 4,814 | |
From Investments | Rs m | -6,867 | 5,826 | -1,485 | 13,062 | -5,208 | |
From Financial Activity | Rs m | 3,382 | -10,157 | 1,943 | -17,094 | -158 | |
Net Cashflow | Rs m | -5,957 | -2,589 | 1,097 | -1,837 | -564 |
Share Holding
Shareholding as on Jun 2022
|
Company Information
|
CHM: Arun Kumar | COMP SEC: Manjula Ramamurthy | YEAR OF INC: 1990 | BSE CODE: 532531 | FV (Rs): 10 | DIV YIELD (%): 0.7 |
More Pharmaceuticals Company Fact Sheets: LUPIN ZYDUS LIFESCIENCES AUROBINDO PHARMA DR. REDDYS LAB SUN PHARMA
Compare STRIDES PHARMA SCIENCE With: LUPIN ZYDUS LIFESCIENCES AUROBINDO PHARMA DR. REDDYS LAB SUN PHARMA
Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.